(Q50303465)

2 March 2018

title

Increased serum levels of epidermal growth factor in children with autism. (English)

1 reference

2 March 2018

0 references

1 reference

Elvan Işeri

1

1 reference

2 March 2018

Esra Güney

2

1 reference

2 March 2018

Mehmet F Ceylan

3

1 reference

2 March 2018

Ayşegül Yücel

4

1 reference

2 March 2018

Arzu Aral

5

1 reference

2 March 2018

Sahin Bodur

6

1 reference

2 March 2018

Sahnur Sener

7

1 reference

2 March 2018

language of work or name

English

0 references

publication date

1 February 2011

1 reference

2 March 2018

Journal of Autism and Developmental Disorders

published in

1 reference

2 March 2018

volume

41

1 reference

2 March 2018

page(s)

237-241

1 reference

2 March 2018

issue

2

1 reference

2 March 2018

https://scigraph.springernature.com/pub.10.1007/s10803-010-1046-3

exact match

0 references

cites work

Trophic actions of transforming growth factor alpha on mesencephalic dopaminergic neurons developing in culture

1 reference

https://api.crossref.org/works/10.1007%2FS10803-010-1046-3

Urinary epidermal and insulin-like growth factor excretion in autistic children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-010-1046-3

A review of autism and the immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-010-1046-3

The immune response in autism: a new frontier for autism research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-010-1046-3

Effects of age on brain volume and head circumference in autism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-010-1046-3

EGF enhances the survival of dopamine neurons in rat embryonic mesencephalon primary cell culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-010-1046-3

The Screening and Diagnosis of Autistic Spectrum Disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-010-1046-3

21 January 2018

The prevalence of autism

1 reference

https://api.crossref.org/works/10.1007%2FS10803-010-1046-3

Neonatal perturbation of neurotrophic signaling results in abnormal sensorimotor gating and social interaction in adults: implication for epidermal growth factor in cognitive development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-010-1046-3

Abnormal expression of epidermal growth factor and its receptor in the forebrain and serum of schizophrenic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-010-1046-3

Increased levels of serum basic fibroblast growth factor in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-010-1046-3

No changes in serum epidermal growth factor levels in patients with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-010-1046-3

Influences of dopaminergic lesion on epidermal growth factor-ErbB signals in Parkinson's disease and its model: neurotrophic implication in nigrostriatal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-010-1046-3

Early language and communication development of infants later diagnosed with autism spectrum disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-010-1046-3

Selected neurotrophins, neuropeptides, and cytokines: developmental trajectory and concentrations in neonatal blood of children with autism or Down syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-010-1046-3

Autism Diagnostic Interview-Revised and the Childhood Autism Rating Scale: convergence and discrepancy in diagnosing autism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-010-1046-3

Toward objective classification of childhood autism: Childhood Autism Rating Scale (CARS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-010-1046-3

Decreased serum levels of epidermal growth factor in adult subjects with high-functioning autism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-010-1046-3

Neuroglial activation and neuroinflammation in the brain of patients with autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-010-1046-3

The role of epidermal growth factor and its receptors in mammalian CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-010-1046-3

Roles of transforming growth factor-alpha and related molecules in the nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-010-1046-3

The neurotrophic action and signalling of epidermal growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10803-010-1046-3

Characterization of human epidermal growth factor in human serum and urine under native conditions

21 January 2018

1 reference

12 December 2020

Epidermal growth factor and basic fibroblast growth factor protect dopaminergic neurons from glutamate toxicity in culture

1 reference

12 December 2020

Epidemiology of autistic disorder and other pervasive developmental disorders

1 reference

12 December 2020

Oxidative stress in autism

1 reference

12 December 2020

SNP analyses of growth factor genes EGF, TGFbeta-1, and HGF reveal haplotypic association of EGF with autism.

1 reference

12 December 2020

Low serum levels of brain-derived neurotrophic factor and epidermal growth factor in patients with chronic schizophrenia

1 reference

12 December 2020

10.1007/S10803-010-1046-3

Identifiers

DOI

1 reference

2 March 2018

PubMed ID

20544265

1 reference

2 March 2018